Hypertension is the world's leading modifiable risk factor for premature death. In 2024, an estimated 1.4 billion adults aged 30–79 lived with hypertension—one in three adults in this age group—yet nearly half are unaware of their condition, and only 23% have it adequately controlled. Uncontrolled high blood pressure claims over 10 million lives annually, mainly through heart attacks, strokes, kidney disease, and dementia. The conclusion is clear: scaling up blood pressure control could prevent hundreds of thousands of deaths every year.

The importance of control lies in its direct link to survival. Each hour, more than 1,000 lives are lost to strokes and heart attacks caused by high blood pressure, most of them preventable. Even modest reductions lower cardiovascular risk substantially; for high-risk patients, intensive treatment has cut major cardiovascular events by 25% and all-cause mortality by 27%. The economic stakes are equally high: from 2011 to 2025, cardiovascular diseases including hypertension were projected to cost low-and middle-income countries about US$3.7 trillion, roughly 2% of their combined GDP.

Effective control requires tailored approaches. For everyone, lifestyle changes are foundational: reducing sodium, following heart-healthy diets such as DASH, exercising regularly, limiting alcohol, and maintaining a healthy weight. For those whose pressure remains elevated, low-cost antihypertensive medicines are highly cost-effective—yet only 28% of low-income countries report general availability of all WHO-recommended medicines, versus 93% of high-income countries. In low- and middle-income countries, where two-thirds of adults with hypertension live, integrating treatment into primary care has produced real progress; Bangladesh, for example, raised control rates from 15% to 56% in some regions between 2019 and 2025. For older adults and those with multiple conditions, co-managing blood pressure, glucose, and lipids is essential.

Daily monitoring empowers patients. The American Heart Association recommends home monitoring with a validated, automatic, upper-arm cuff-style monitor; wrist and finger devices are less reliable. Sit quietly for five minutes, avoid caffeine, exercise, and smoking for 30 minutes beforehand, and take two readings one minute apart. Bringing the monitor to appointments verifies accuracy; pharmacy or clinic checks offer alternatives.

In summary, with 1.4 billion people living with hypertension and only a fraction controlled, the costs of inaction are immense. Yet the tools exist—lifestyle change, affordable medicines, primary care integration, and home monitoring. Closing the treatment gap would prevent over half a million deaths each year and rank among the most impactful public health achievements of our time.